Process of Preparation of Erlotinib
This technology is related to process of preparing of Erlotinib. What is the Novelty? The earlier technologies for preparing [6,7-bis-(2methoxyethoxy)-quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride (Erlotinib) having low yield about 50% -75% whereas present technology gives high yield, in addition has significant advantage in terms of time and cost. This technology can produce Erlotinib in less synthetic steps.
Sector: Fluid systems and components for general use
Country: India
Area of Application: Medical indsutry.
Keywords: Erlotinib,tyrosine kinase.
Advantages: Non-Infringing method of producing Erlotinib. Cost Effective drug. High yield compared to earlier Erlotinib production. methods Huge market opportunity. FDA approval for Erlotinib.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054
Contact Technology Provider
Technology offer
Interested in this technology?
Request further information or explore potential cooperation with the technology provider.
Technology request
Can you help meet this technology need?
Share a relevant technology, expertise or partnership opportunity with APCTT.